Compare Avalanche Treasury Corporation Class A Common Stock (AVAT) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avalanche Treasury Corporation Class A Common Stock vs Heron Therapeutics Inc — how do they compare? Avalanche Treasury Corporation Class A Common Stock trades at $0.34 (market cap $15.33M), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Heron Therapeutics Inc is far larger — about 4× Avalanche Treasury Corporation Class A Common Stock's market cap. Which is the better fit depends on your goals.
| AVAT | HRTX | |
|---|---|---|
Market Cap | $15.33M | $61.47M |
Sector | Financials | Health |
52-Week High | $10.75 | $1.49 |
52-Week Low | $0.30 | $0.32 |
Enterprise Value | $15.33M | $168.21M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Avalanche Treasury Corporation Class A Common Stock
Avalanche Treasury Corp operates as a digital asset treasury company focused on holding and managing digital asset investments. The company was founded on September 22, 2025, and is headquartered in New York, NY.
Read more on AVAT →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
